性能参数

产品名称

Bortezomib

规格

10mM (in 1mL DMSO) 10mg 25mg 100mg 500mg

货号

GOY-Y2274

 含量

>98.00%

CAS

179324-69-7

别名

Bortezomib,PS-341,LDP-341,MLM341,MG-341,NSC-681239

化学名

[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid

分子式

C19H25BN4O4

分子量

分子 384.24

溶解度

≥ 19.212mg/mL in DMSO

储存条件

4°C, protect from light

General tips

用途

仅供科研

价格

电询

详细内容

A potent (Ki = 0.6 nM), specific and reversible proteasome inhibitor. It inhibits cell proliferation of H460 cells (Human non-small cell lung cancer cell lines) with an IC?? of 0.1 μM.

References:

1. Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach. 11 ed. 2008.

2. Gelman JS, Sironi J, Berezniuk I, Dasgupta S, Castro LM, Gozzo FC, Ferro ES, Fricker LD (2013). "Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomib". In Gartel, Andrei L. PLoS One 8 (8): e53263.

聚乙二醇 average Mn 4000  十五烷 standard for GC, ≥99.5% (GC)

聚乙二醇 average Mn 6000  十五烷 99%

聚乙二醇 average Mn 800  十五烷 98%

聚乙二醇 average Mn 600  十五烷 分析标准品，≥99.8% (GC)

聚乙二醇 average Mn 300  地塞米松磷酸钠 98%

聚乙二醇 average Mn 20000  泼尼松 98%

ZAP 18001310 mg 50 mg>98.00%Cas No. 873080-25-2C19H17Cl2N3O4S

XY 01810 mg 50 mg>98.00%Cas No. 1873358-87-2C23H15F7N2O4

Gefitinib (ZD1839)10mM (in 1mL DMSO) 100mg 250mg>98.00%Cas No. 184475-35-2C22H24ClFN4O3

GIP (1-30) amide,Human acetate1mg 5mg 10mg>98.00%Cas No. N/AC164H244N40O49S

Ginsenoside Rg510mM*1mLinDMSO 5mg 10mg>98.00%Cas No. 186763-78-0C42H70O12

GS-997310mM (in 1mL DMSO) 10mg 25mg>98.00%Cas No. 1229208-44-9C23H21N7O

GNF-710mM (in 1mL DMSO) 5mg 25mg>98.00%Cas No. 839706-07-9C28H24F3N7O2